Epstein-Barr virus (EBV) is typically found in a latent, asymptomatic state in immuno-competent individuals. Perturbations of the host immune system can stimulate viral reactivation. Furthermore, there are a myriad of EBV-associated illnesses including various cancers, post-transplant lymphoproliferative disease, and autoimmune conditions. A thorough understanding of this virus, and the interplay between stress and the immune system, is essential to establish effective treatment. This review will provide a summary of the interaction between both psychological and cellular stressors resulting in EBV reactivation. It will examine mechanisms by which EBV establishes and maintains latency and will conclude with a brief overview of treatments targeting EBV.
CITATION STYLE
Sausen, D. G., Bhutta, M. S., Gallo, E. S., Dahari, H., & Borenstein, R. (2021, September 1). Stress-induced epstein-barr virus reactivation. Biomolecules. MDPI. https://doi.org/10.3390/biom11091380
Mendeley helps you to discover research relevant for your work.